IACCARINO, Ciro
 Distribuzione geografica
Continente #
NA - Nord America 2.719
AS - Asia 1.426
SA - Sud America 879
EU - Europa 852
AF - Africa 65
Continente sconosciuto - Info sul continente non disponibili 6
Totale 5.947
Nazione #
US - Stati Uniti d'America 2.651
BR - Brasile 794
SG - Singapore 556
CN - Cina 479
UA - Ucraina 227
IT - Italia 205
DE - Germania 120
HK - Hong Kong 86
VN - Vietnam 74
SE - Svezia 57
FI - Finlandia 55
GB - Regno Unito 53
IN - India 31
KR - Corea 30
MX - Messico 29
TR - Turchia 27
RU - Federazione Russa 26
AR - Argentina 23
BD - Bangladesh 23
CA - Canada 21
ZA - Sudafrica 21
EC - Ecuador 20
NL - Olanda 19
PL - Polonia 19
IQ - Iraq 18
JP - Giappone 17
BE - Belgio 15
UZ - Uzbekistan 14
FR - Francia 12
PK - Pakistan 11
CO - Colombia 10
MA - Marocco 10
SA - Arabia Saudita 10
VE - Venezuela 9
ID - Indonesia 8
CZ - Repubblica Ceca 7
PY - Paraguay 7
KE - Kenya 6
TN - Tunisia 6
UY - Uruguay 6
AT - Austria 5
EG - Egitto 5
ES - Italia 5
KZ - Kazakistan 5
LT - Lituania 5
PA - Panama 5
PE - Perù 5
AZ - Azerbaigian 4
DZ - Algeria 4
IL - Israele 4
LB - Libano 4
MD - Moldavia 4
AO - Angola 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
EU - Europa 3
HN - Honduras 3
IR - Iran 3
KG - Kirghizistan 3
KW - Kuwait 3
PT - Portogallo 3
SN - Senegal 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
CL - Cile 2
CR - Costa Rica 2
DK - Danimarca 2
DM - Dominica 2
JO - Giordania 2
MY - Malesia 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
PS - Palestinian Territory 2
RO - Romania 2
RS - Serbia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CG - Congo 1
CI - Costa d'Avorio 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
IM - Isola di Man 1
LI - Liechtenstein 1
ML - Mali 1
NG - Nigeria 1
PH - Filippine 1
QA - Qatar 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
Totale 5.947
Città #
Dallas 1.313
Chandler 303
Singapore 295
Jacksonville 136
Beijing 122
Sassari 88
Hong Kong 86
Princeton 84
Ashburn 80
Nanjing 64
Ann Arbor 62
New York 49
São Paulo 47
Shanghai 44
Dearborn 37
Seoul 30
Wilmington 29
Nanchang 27
Ho Chi Minh City 24
Belo Horizonte 22
Los Angeles 22
Santa Clara 22
Boardman 21
Helsinki 21
Shenyang 21
Jinan 19
Tianjin 19
Rio de Janeiro 18
Warsaw 17
Brussels 15
Frankfurt am Main 15
Hebei 15
Tokyo 15
Council Bluffs 14
Curitiba 14
Hanoi 14
Johannesburg 14
Tashkent 14
Woodbridge 14
Changsha 13
Munich 13
Poplar 13
San Francisco 12
Stockholm 12
Guangzhou 10
Zhengzhou 10
Brooklyn 9
Campo Grande 9
Mexico City 9
Mountain View 9
Ningbo 9
Betim 8
Brasília 8
Campinas 8
Chicago 8
Columbus 8
Guarulhos 8
Joinville 8
Niterói 8
Quito 8
Salvador 8
Toronto 8
Baghdad 7
Boston 7
Denver 7
Dhaka 7
Guayaquil 7
Juiz de Fora 7
Norwalk 7
Pelotas 7
Porto Alegre 7
Ribeirão Preto 7
The Dalles 7
Amsterdam 6
Atlanta 6
Bragança Paulista 6
Cagliari 6
Cotia 6
Haikou 6
Orem 6
Osasco 6
Sumaré 6
Taizhou 6
Andover 5
Bauru 5
Buffalo 5
Canelli 5
Caracas 5
Chennai 5
Contagem 5
Falls Church 5
Houston 5
Izmir 5
Jeddah 5
Jiaxing 5
Lappeenranta 5
Manaus 5
Manchester 5
Mauá 5
Montevideo 5
Totale 3.704
Nome #
null 509
Design, anticancer activity, and mechanistic evaluation of a novel class of selective human carbonic anhydrase IX inhibitors featuring a trifluorodihydroxypropanone pharmacophore 227
Prune melanoidins protect against oxidative stress and endothelial cell death 173
Exploring Heteroaryl-pyrazole Carboxylic Acids as Human Carbonic Anhydrase XII Inhibitors 169
ALTERATION IN VESICLE TRAFFICKING IN PARKINSON’S DISEASE: FROM PATHOLOGICAL MOLECULAR MECHANISMS TO THERAPEUTIC OPTION 168
Role of LRRK2 in the regulation of dopamine receptor trafficking. 163
Epigenetic changes associated with the expression of Amyotrophic Lateral Sclerosis (ALS) causing genes 160
LRRK2 Modulates the Exocyst Complex Assembly by Interacting with Sec8 153
AMYOTROPHIC LATERAL SCLEROSIS AND TDP-43: AN EPIGENETIC LIAISON 151
Levetiracetam treatment ameliorates LRRK2 pathological mutant phenotype 140
Cyanotoxins exposure and TDP-43 physiopathology: a molecular study 139
Bcl2-A1 interacts with pro-caspase-3: Implications for amyotrophic lateral sclerosis 130
Apoptotic mechanisms in mutant LRRK2-mediated cell death 129
Alternative splicing of pro- and anti-apoptotic genes in amyotrophic lateral sclerosis 129
Dual control of dopamine synthesis and release by pre- and postsynaptic dopamine D2 receptors 127
Functional analysis of TDP43: interaction with the epigenetic machinery 127
Differential protein-protein interactions of LRRK1 and LRRK2 indicate roles in distinct cellular signaling pathways 125
Control of Lactotrop Proliferation by Dopamine: Essential Role of Signalling Through D2 Receptors and ERKs 122
EFFECT OF LRRK2 PATHOLOGICAL MUTATION ON DOPAMINE METABOLISM IN PC12 CELLS 122
Astroglial inhibition of NF-kappaB does not ameliorate disease onset and progression in a mouse model for amyotrophic lateral sclerosis (ALS) 122
Bcl2a1 serves as a switch in death of motor neurons in amyotrophic lateral sclerosis 121
Redox-sensitive GFP to monitor oxidative stress in neurodegenerative diseases 121
Inhibition of receptor-dependent urokinase signalling by specific Ser to Glu substitutions 118
Single-step green synthesis and characterization of gold-conjugated polyphenol nanoparticles with antioxidant and biological activities 116
HDAC1 inhibition ameliorates TDP-43-induced cell death in vitro and in vivo 116
Astroglial inhibition of NF-κB does not ameliorate disease onset and progression in a mouse model for Amyotrophic Lateral Sclerosis (ALS) 116
Cyanobacteria, cyanotoxins, and neurodegenerative diseases: Dangerous liaisons 110
Neurobiological features of dopamine D2 receptors. Distinct functions of D2L and D2S in vivo 107
Bcl2a1 role in familial Amyotrophic Lateral Sclerosis (ALS) 105
GFP-based reporters to monitor biochemical alteration in cellular models for Amyotrophic Lateral Sclerosis 104
Role of LRRK2 in the regulation of dopamine receptor trafficking 104
Phosphorylation of human pro-urokinase on Ser138/303 impairs its receptor-dependent ability to promote myelomonocytic adherence and motility 97
Simultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice 95
The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity 94
Natural polyphenols for one pot green synthesis and stabilization of gold nanoparticles with antioxidant and biological activities 93
Evaluation of Neuroinflammatory Contribution to Neurodegeneration in LRRK2 Drosophila Models 91
Understanding the function of dopamine D2 receptor : A knock-out animal approach 89
LRRK2 in Drosophila Melanogaster Model: Insights into Cellular Dysfunction and Neuroinflammation in Parkinson’s Disease 86
LRRK2 and vesicle trafficking 85
Regulatory roles of hnRNP M and Nova-1 in the alternative splicing of the dopamine D2 receptor pre-mRNA 84
SOD1-LINKED FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS: UNDERSTANDING THE TOXIC FUNCTION OF THE MUTANT ENZYMES 83
Parkinson’s disease-related genes and lipid alteration 80
PROTEIN KINASE C-DEPENDENT IN VIVO PHOSPHORYLATION OF PROUROKINASE LEADS TO THE FORMATION OF A RECEPTOR COMPETITIVE ANTAGONIST 79
Evaluation of cyanotoxin L-BMAA effect on α-synuclein and TDP43 proteinopathy 77
Inhibition of the Exocyst Complex Attenuates the LRRK2 Pathological Effects 76
LRRK2 affects vesicle trafficking, neurotransmitter extracellular level and membrane receptor localization 71
Prune melanoidins protect endothelial cell against oxidative stress and mitochondria-mediated cell death 65
Simultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice 60
PAK6 rescues pathogenic LRRK2-mediated ciliogenesis and centrosomal cohesion defects in a mutation-specific manner 51
Design, anticancer activity, and mechanistic evaluation of a novel class of selective human carbonic anhydrase IX inhibitors featuring a trifluorodihydroxypropanone pharmacophore 26
Totale 6.005
Categoria #
all - tutte 21.359
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.359


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021189 0 0 0 0 0 5 49 14 62 43 10 6
2021/2022261 23 2 7 5 2 9 8 12 36 40 27 90
2022/2023542 50 61 15 94 45 86 4 66 79 5 27 10
2023/2024218 24 13 2 8 24 35 24 5 0 11 34 38
2024/20251.665 7 8 102 49 80 65 120 315 514 262 93 50
2025/20262.304 139 400 1.094 385 244 42 0 0 0 0 0 0
Totale 6.005